Selected article for: "available evidence and infection patient"

Author: Preckel, Benedikt; Schultz, Marcus J.; Vlaar, Alexander P.; Hulst, Abraham H.; Hermanides, Jeroen; de Jong, Menno D.; Schlack, Wolfgang S.; Stevens, Markus F.; Weenink, Robert P.; Hollmann, Markus W.
Title: Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
  • Cord-id: cfqfchk4
  • Document date: 2020_5_15
  • ID: cfqfchk4
    Snippet: When preparing for the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the coronavirus infection disease (COVID-19) questions arose regarding various aspects concerning the anaesthetist. When reviewing the literature it became obvious that keeping up-to-date with all relevant publications is almost impossible. We searched for and summarised clinically relevant topics that could help making clinical decisions. This is a subjective analysis of literature conc
    Document: When preparing for the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the coronavirus infection disease (COVID-19) questions arose regarding various aspects concerning the anaesthetist. When reviewing the literature it became obvious that keeping up-to-date with all relevant publications is almost impossible. We searched for and summarised clinically relevant topics that could help making clinical decisions. This is a subjective analysis of literature concerning specific topics raised in our daily practice (e.g., clinical features of COVID-19 patients; ventilation of the critically ill COVID-19 patient; diagnostic of infection with SARS-CoV-2; stability of the virus; Covid-19 in specific patient populations, e.g., paediatrics, immunosuppressed patients, patients with hypertension, diabetes mellitus, kidney or liver disease; co-medication with non-steroidal anti-inflammatory drugs (NSAIDs); antiviral treatment) and we believe that these answers help colleagues in clinical decision-making. With ongoing treatment of severely ill COVID-19 patients other questions will come up. While respective guidelines on these topics will serve clinicians in clinical practice, regularly updating all guidelines concerning COVID-19 will be a necessary, although challenging task in the upcoming weeks and months. All recommendations during the current extremely rapid development of knowledge must be evaluated on a daily basis, as suggestions made today may be out-dated with the new evidence available tomorrow.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and accurate detection: 1, 2
    • abdominal pain and ace enzyme: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and acute aki kidney injury: 1, 2, 3, 4, 5, 6
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abnormal liver and acute aki kidney injury: 1, 2, 3
    • abnormal liver and acute ards respiratory distress syndrome: 1
    • accurate detection and acute ards respiratory distress syndrome: 1
    • ace enzyme and acute aki kidney injury: 1, 2, 3, 4, 5, 6, 7
    • ace enzyme and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor and acute aki kidney injury: 1, 2, 3
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • actual body weight and acute aki kidney injury: 1
    • actual body weight and acute ards respiratory distress syndrome: 1